Literature DB >> 31203003

Iodine ion doped bromo bismuth oxide modified bismuth germanate: A direct Z-scheme photocatalyst with enhanced visible-light photocatalytic performance.

Xiaowen Ruan1, Hao Hu1, Guangbo Che2, Pengjie Zhou3, Chunbo Liu4, Hongjun Dong5.   

Abstract

A series of Z-scheme I-BiOBr/Bi12GeO20 heterostructures were successfully obtained by a simple method. The Z-scheme I-BiOBr/Bi12GeO20 heterostructures show outstanding photocatalytic performance for degrading the various organic pollutants of the waste water. For degradation of Tetracycline (TC), the Z-scheme 30I-BiOBr/Bi12GeO20 heterostructure exhibits the superior rate constant, which is about 7.73 times, 3.52 times and 1.66 times higher than that of the pure Bi12GeO20, BiOBr and I-BiOBr, respectively. Meanwhile, as we expected, the Z-scheme 30I-BiOBr/Bi12GeO20 heterostructure also displays the enhanced photocatalytic perfomance for degradation of Ciprofloxacin (CIP), 2-Mercaptobenzothiazole (MBT) and reduction of aqueous Cr(VI). The enhancement of photocatalytic performance is attributed to the high redox capacity and the strong interfacial interaction between I-BiOBr and Bi12GeO20, which can effectively improve the separation of photo-induced electron-hole pairs. Additionally, the photocatalytic mechanism over the Z-scheme I-BiOBr/Bi12GeO20 heterostructure is provided. The research work may provide a promising approach to fabricate other Z-scheme heterostructures with efficient photocatalytic performance.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Degradation pathways; Doping I(−) ions; I-BiOBr/Bi(12)GeO(20) heterostructure; Photocatalytic degradation and reduction; Z-scheme

Year:  2019        PMID: 31203003     DOI: 10.1016/j.jcis.2019.06.007

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  1 in total

1.  Fabrication of metal-free PTET-T-COOH/g-C3N4 heterostructure for enhancing photocatalytic activity.

Authors:  Linlin Liu; Xingyue Song; Xiangxin Kong; Qian Duan; Enwei Zhu
Journal:  RSC Adv       Date:  2020-03-03       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.